• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SARS-CoV-2 感染个体的疫苗接种会扩增广泛的、克隆多样化的亲和力成熟的 B 细胞谱系。

Vaccination of SARS-CoV-2-infected individuals expands a broad range of clonally diverse affinity-matured B cell lineages.

机构信息

Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.

Adimab LLC, Lebanon, NH, 03766, USA.

出版信息

Nat Commun. 2023 Apr 19;14(1):2249. doi: 10.1038/s41467-023-37972-1.

DOI:10.1038/s41467-023-37972-1
PMID:37076511
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10115384/
Abstract

Vaccination of SARS-CoV-2 convalescent individuals generates broad and potent antibody responses. Here, we isolate 459 spike-specific monoclonal antibodies (mAbs) from two individuals who were infected with the index variant of SARS-CoV-2 and later boosted with mRNA-1273. We characterize mAb genetic features by sequence assignments to the donors' personal immunoglobulin genotypes and assess antibody neutralizing activities against index SARS-CoV-2, Beta, Delta, and Omicron variants. The mAbs used a broad range of immunoglobulin heavy chain (IGH) V genes in the response to all sub-determinants of the spike examined, with similar characteristics observed in both donors. IGH repertoire sequencing and B cell lineage tracing at longitudinal time points reveals extensive evolution of SARS-CoV-2 spike-binding antibodies from acute infection until vaccination five months later. These results demonstrate that highly polyclonal repertoires of affinity-matured memory B cells are efficiently recalled by vaccination, providing a basis for the potent antibody responses observed in convalescent persons following vaccination.

摘要

SARS-CoV-2 康复个体的疫苗接种会产生广泛而有效的抗体反应。在这里,我们从两名感染了 SARS-CoV-2 原始变体并随后接种 mRNA-1273 的个体中分离出 459 种刺突特异性单克隆抗体(mAb)。我们通过将 mAb 序列分配给供体的个人免疫球蛋白基因型来表征 mAb 的遗传特征,并评估针对原始 SARS-CoV-2、Beta、Delta 和 Omicron 变体的抗体中和活性。在对所有检查的刺突亚决定簇的反应中,mAb 使用了广泛的免疫球蛋白重链(IGH)V 基因,在两个供体中观察到相似的特征。IGH 库测序和纵向时间点的 B 细胞谱系追踪显示,从急性感染到五个月后接种疫苗期间,SARS-CoV-2 刺突结合抗体经历了广泛的进化。这些结果表明,高效价的亲和力成熟记忆 B 细胞多克隆库可通过疫苗接种有效召回,为康复个体接种疫苗后观察到的强烈抗体反应提供了基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bab7/10115778/f0c21c0b660d/41467_2023_37972_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bab7/10115778/96dccfb24591/41467_2023_37972_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bab7/10115778/76b17d084c3a/41467_2023_37972_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bab7/10115778/2df4d40c16c9/41467_2023_37972_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bab7/10115778/25cda9d1e0b0/41467_2023_37972_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bab7/10115778/f0c21c0b660d/41467_2023_37972_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bab7/10115778/96dccfb24591/41467_2023_37972_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bab7/10115778/76b17d084c3a/41467_2023_37972_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bab7/10115778/2df4d40c16c9/41467_2023_37972_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bab7/10115778/25cda9d1e0b0/41467_2023_37972_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bab7/10115778/f0c21c0b660d/41467_2023_37972_Fig5_HTML.jpg

相似文献

1
Vaccination of SARS-CoV-2-infected individuals expands a broad range of clonally diverse affinity-matured B cell lineages.SARS-CoV-2 感染个体的疫苗接种会扩增广泛的、克隆多样化的亲和力成熟的 B 细胞谱系。
Nat Commun. 2023 Apr 19;14(1):2249. doi: 10.1038/s41467-023-37972-1.
2
Emerging Variants of SARS-CoV-2 and Novel Therapeutics Against Coronavirus (COVID-19)严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的新变种及针对冠状病毒(COVID-19)的新型疗法
3
Neutralisation sensitivity of the SARS-CoV-2 omicron (B.1.1.529) variant: a cross-sectional study.奥密克戎(B.1.1.529)变异株的中和敏感性:一项横断面研究。
Lancet Infect Dis. 2022 Jun;22(6):813-820. doi: 10.1016/S1473-3099(22)00129-3. Epub 2022 Mar 17.
4
Analysis of B Cell Receptor Repertoires Reveals Key Signatures of the Systemic B Cell Response after SARS-CoV-2 Infection.分析 B 细胞受体文库揭示了 SARS-CoV-2 感染后系统性 B 细胞反应的关键特征。
J Virol. 2022 Feb 23;96(4):e0160021. doi: 10.1128/JVI.01600-21. Epub 2021 Dec 8.
5
Identification and Analysis of Monoclonal Antibodies with Neutralizing Activity against Diverse SARS-CoV-2 Variants.鉴定和分析针对多种 SARS-CoV-2 变体具有中和活性的单克隆抗体。
J Virol. 2023 Jun 29;97(6):e0028623. doi: 10.1128/jvi.00286-23. Epub 2023 May 16.
6
Resistance of SARS-CoV-2 variants to neutralization by antibodies induced in convalescent patients with COVID-19.SARS-CoV-2 变异株对 COVID-19 恢复期患者体内诱导产生的抗体中和作用的抗性。
Cell Rep. 2021 Jul 13;36(2):109385. doi: 10.1016/j.celrep.2021.109385. Epub 2021 Jun 25.
7
Deep immunoglobulin repertoire sequencing depicts a comprehensive atlas of spike-specific antibody lineages shared among COVID-19 convalescents.深度免疫球蛋白库测序描绘了 COVID-19 康复者中共享的刺突特异性抗体谱系的综合图谱。
Emerg Microbes Infect. 2024 Dec;13(1):2290841. doi: 10.1080/22221751.2023.2290841. Epub 2024 Jan 24.
8
SARS-CoV-2 spike-reactive naïve B cells and pre-existing memory B cells contribute to antibody responses in unexposed individuals after vaccination.接种疫苗后,SARS-CoV-2 刺突反应性幼稚 B 细胞和预先存在的记忆 B 细胞有助于未暴露个体的抗体反应。
Front Immunol. 2024 Feb 14;15:1355949. doi: 10.3389/fimmu.2024.1355949. eCollection 2024.
9
Neutralizing and enhancing monoclonal antibodies in SARS-CoV-2 convalescent patients: lessons from early variant infection and impact on shaping emerging variants.SARS-CoV-2 恢复期患者体内中和与增强型单克隆抗体:早期变异株感染的经验教训及其对新兴变异株形成的影响。
Emerg Microbes Infect. 2024 Dec;13(1):2307510. doi: 10.1080/22221751.2024.2307510. Epub 2024 Jan 30.
10
Antibody Avidity and Neutralizing Response against SARS-CoV-2 Omicron Variant after Infection or Vaccination.感染或接种疫苗后针对 SARS-CoV-2 奥密克戎变异株的抗体亲合力和中和反应。
J Immunol Res. 2022 Aug 31;2022:4813199. doi: 10.1155/2022/4813199. eCollection 2022.

引用本文的文献

1
Humoral and Memory B Cell Responses Following SARS-CoV-2 Infection and mRNA Vaccination.新型冠状病毒2感染及mRNA疫苗接种后的体液和记忆B细胞反应
Vaccines (Basel). 2025 Jul 28;13(8):799. doi: 10.3390/vaccines13080799.
2
The immunological impact of revaccination in a hybrid-immune world.在混合免疫的世界中再次接种疫苗的免疫学影响。
Front Immunol. 2025 Jun 9;16:1588259. doi: 10.3389/fimmu.2025.1588259. eCollection 2025.
3
Naive and Memory B Cell BCR Repertoires in Individuals Immunized with an Inactivated SARS-CoV-2 Vaccine.接种灭活新冠病毒疫苗个体中的初始B细胞和记忆B细胞BCR库

本文引用的文献

1
A public antibody class recognizes an S2 epitope exposed on open conformations of SARS-CoV-2 spike.一种公共抗体类别识别 SARS-CoV-2 刺突蛋白开放构象上暴露的 S2 表位。
Nat Commun. 2022 Aug 4;13(1):4539. doi: 10.1038/s41467-022-32232-0.
2
Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5.SARS-CoV-2 奥密克戎亚变种 BA.2.12.1、BA.4 和 BA.5 的抗体逃逸
Nature. 2022 Aug;608(7923):603-608. doi: 10.1038/s41586-022-05053-w. Epub 2022 Jul 5.
3
Emergence of SARS-CoV-2 Omicron lineages BA.4 and BA.5 in South Africa.
Vaccines (Basel). 2025 Apr 8;13(4):393. doi: 10.3390/vaccines13040393.
4
Detection of PCR chimeras in adaptive immune receptor repertoire sequencing using hidden Markov models.使用隐马尔可夫模型在适应性免疫受体组库测序中检测PCR嵌合体。
bioRxiv. 2025 Feb 26:2025.02.21.638809. doi: 10.1101/2025.02.21.638809.
5
Disease diagnostics using machine learning of B cell and T cell receptor sequences.利用B细胞和T细胞受体序列的机器学习进行疾病诊断
Science. 2025 Feb 21;387(6736):eadp2407. doi: 10.1126/science.adp2407.
6
Navigating the Landscape of B Cell Mediated Immunity and Antibody Monitoring in SARS-CoV-2 Vaccine Efficacy: Tools, Strategies and Clinical Trial Insights.探索SARS-CoV-2疫苗效力中B细胞介导的免疫和抗体监测领域:工具、策略及临床试验见解
Vaccines (Basel). 2024 Sep 24;12(10):1089. doi: 10.3390/vaccines12101089.
7
A single-dose MCMV-based vaccine elicits long-lasting immune protection in mice against distinct SARS-CoV-2 variants.一种单次剂量的基于 MCMV 的疫苗可在小鼠中引发针对不同 SARS-CoV-2 变体的持久免疫保护。
Front Immunol. 2024 Jul 25;15:1383086. doi: 10.3389/fimmu.2024.1383086. eCollection 2024.
8
Dissecting human monoclonal antibody responses from mRNA- and protein-based XBB.1.5 COVID-19 monovalent vaccines.剖析基于mRNA和蛋白质的XBB.1.5新冠病毒单价疫苗引发的人类单克隆抗体反应。
bioRxiv. 2024 Jul 16:2024.07.15.602781. doi: 10.1101/2024.07.15.602781.
9
Multi-compartmental diversification of neutralizing antibody lineages dissected in SARS-CoV-2 spike-immunized macaques.SARS-CoV-2 刺突蛋白免疫的猕猴中中和抗体谱系的多室多样化。
Nat Commun. 2024 Jul 27;15(1):6338. doi: 10.1038/s41467-024-50286-0.
南非出现 SARS-CoV-2 奥密克戎变异株 BA.4 和 BA.5。
Nat Med. 2022 Sep;28(9):1785-1790. doi: 10.1038/s41591-022-01911-2. Epub 2022 Jun 27.
4
Recall of preexisting cross-reactive B cell memory after Omicron BA.1 breakthrough infection.奥密克戎 BA.1 突破感染后预先存在的交叉反应性 B 细胞记忆的召回。
Sci Immunol. 2022 Jul 29;7(73):eabq3511. doi: 10.1126/sciimmunol.abq3511.
5
Analysis of memory B cells identifies conserved neutralizing epitopes on the N-terminal domain of variant SARS-Cov-2 spike proteins.分析记忆 B 细胞鉴定出变异 SARS-CoV-2 刺突蛋白 N 端结构域上的保守中和表位。
Immunity. 2022 Jun 14;55(6):998-1012.e8. doi: 10.1016/j.immuni.2022.04.003. Epub 2022 Apr 7.
6
Increased memory B cell potency and breadth after a SARS-CoV-2 mRNA boost.接种 SARS-CoV-2 mRNA 加强针后,记忆 B 细胞的效力和广度增加。
Nature. 2022 Jul;607(7917):128-134. doi: 10.1038/s41586-022-04778-y. Epub 2022 Apr 21.
7
Structural definition of a pan-sarbecovirus neutralizing epitope on the spike S2 subunit.刺突 S2 亚基上泛沙贝科病毒中和表位的结构定义。
Commun Biol. 2022 Apr 11;5(1):342. doi: 10.1038/s42003-022-03262-7.
8
Secondary influenza challenge triggers resident memory B cell migration and rapid relocation to boost antibody secretion at infected sites.二次流感病毒感染会触发驻留记忆 B 细胞迁移,并迅速重新定位,以促进感染部位的抗体分泌。
Immunity. 2022 Apr 12;55(4):718-733.e8. doi: 10.1016/j.immuni.2022.03.003. Epub 2022 Mar 28.
9
Neutralisation sensitivity of the SARS-CoV-2 omicron (B.1.1.529) variant: a cross-sectional study.奥密克戎(B.1.1.529)变异株的中和敏感性:一项横断面研究。
Lancet Infect Dis. 2022 Jun;22(6):813-820. doi: 10.1016/S1473-3099(22)00129-3. Epub 2022 Mar 17.
10
Boosting of cross-reactive antibodies to endemic coronaviruses by SARS-CoV-2 infection but not vaccination with stabilized spike.SARS-CoV-2 感染而非稳定 Spike 疫苗接种可增强对地方性冠状病毒的交叉反应性抗体
Elife. 2022 Mar 15;11:e75228. doi: 10.7554/eLife.75228.